Literature DB >> 25279359

Atrial fibrillation after isolated coronary surgery. Incidence, long term effects and relation with operative technique.

C Rostagno1, C Blanzola2, F Pinelli3, A Rossi3, E Carone2, P L Stefàno2.   

Abstract

INTRODUCTION: Postoperative atrial fibrillation after isolated coronary revascularization has been associated with increased morbidity and mortality. Aim of present investigation was to evaluate incidence of postoperative atrial fibrillation and its prognostic role in patients undergoing isolated coronary artery by-pass and disclose possible differences between off-pump and cardiopulmonary assisted revascularization.
METHODS: Prospective cohort study of 229 patients undergoing isolated coronary artery by-pass at a tertiary heart surgery Centre. Off-pump treated patients were significantly older (70.5 vs 64.9 years, p<0.001). No other baseline differences were found. Patients who developed postoperative atrial fibrillation were followed up for an average period of 2 years.
RESULTS: Post-operative occurred in 56/229 (24.1% after cardiopulmonary and 24.6% after off-pump coronary artery by-pass). Left atrium diameter was the only independent predictive factor (odds ratio =1.15, 95% confidence interval 1.02-1.30, p<0.001). All patients with postoperative atrial fibrillation were treated and discharged in sinus rhythm, in 6/56 recurred, only in one persisted. One patient died during follow up. No stroke was recorded.
CONCLUSIONS: After isolated surgical revascularization, atrial fibrillation occurred in 24% without differences related to operative technique. Recurrence of atrial fibrillation occurred in 6/56 patients (10.7%) however only in 1 persisted. Early and late mortality did not show relation with post-operative atrial fibrillation probably due to immediate treatment with recovery of sinus rhythm before discharge.

Entities:  

Keywords:  atrial fibrillation; cardiac revascularization; mortality; stroke

Year:  2014        PMID: 25279359      PMCID: PMC4181278     

Source DB:  PubMed          Journal:  Heart Lung Vessel        ISSN: 2282-8419


  20 in total

1.  Resource utilization related to atrial fibrillation after coronary artery bypass grafting.

Authors:  Marilyn Hravnak; Leslie A Hoffman; Melissa I Saul; Thomas G Zullo; Gayle R Whitman
Journal:  Am J Crit Care       Date:  2002-05       Impact factor: 2.228

2.  Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. MultiCenter Study of Perioperative Ischemia Research Group.

Authors:  J P Mathew; R Parks; J S Savino; A S Friedman; C Koch; D T Mangano; W S Browner
Journal:  JAMA       Date:  1996 Jul 24-31       Impact factor: 56.272

3.  ACCF/ASE/ACEP/ASNC/SCAI/SCCT/SCMR 2007 appropriateness criteria for transthoracic and transesophageal echocardiography: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American Society of Echocardiography, American College of Emergency Physicians, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society for Cardiovascular Magnetic Resonance. Endorsed by the American College of Chest Physicians and the Society of Critical Care Medicine.

Authors:  Pamela S Douglas; Bijoy Khandheria; Raymond F Stainback; Neil J Weissman; Ralph G Brindis; Manesh R Patel; Joseph S Alpert; David Fitzgerald; Paul Heidenreich; Edward T Martin; Joseph V Messer; Alan B Miller; Michael H Picard; Paolo Raggi; Kim D Reed; John S Rumsfeld; Anthony E Steimle; Russ Tonkovic; Krishnaswami Vijayaraghavan; Susan Bok Yeon; Robert C Hendel; Eric Peterson; Michael J Wolk; Joseph M Allen
Journal:  J Am Soc Echocardiogr       Date:  2007-07       Impact factor: 5.251

4.  Emergency coronary artery bypass graft surgery for acute coronary syndrome: beating heart versus conventional cardioplegic cardiac arrest strategies.

Authors:  Ardawan Julian Rastan; Judith Isabell Eckenstein; Bettina Hentschel; Anne Kathrin Funkat; Jan Fritz Gummert; Nicolas Doll; Thomas Walther; Volkmar Falk; Friedrich Wilhelm Mohr
Journal:  Circulation       Date:  2006-07-04       Impact factor: 29.690

5.  In-hospital outcomes of off-pump versus on-pump coronary artery bypass procedures: a multicenter experience.

Authors:  F Hernandez; W E Cohn; Y R Baribeau; J F Tryzelaar; D C Charlesworth; R A Clough; J D Klemperer; J R Morton; B M Westbrook; E M Olmstead; G T O'Connor
Journal:  Ann Thorac Surg       Date:  2001-11       Impact factor: 4.330

6.  Perioperative serum troponin I levels are associated with higher risk for atrial fibrillation in patients undergoing coronary artery bypass graft surgery.

Authors:  João Carlos Leal; Orlando Petrucci; Moacir Fernandes Godoy; Domingo Marcolino Braile
Journal:  Interact Cardiovasc Thorac Surg       Date:  2011-11-15

7.  Early outcome after off-pump versus on-pump coronary bypass surgery: results from a randomized study.

Authors:  D van Dijk; A P Nierich; E W Jansen; H M Nathoe; W J Suyker; J C Diephuis; W J van Boven; C Borst; E Buskens; D E Grobbee; E O Robles De Medina; P P de Jaegere
Journal:  Circulation       Date:  2001-10-09       Impact factor: 29.690

Review 8.  Intraoperative interventions: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery.

Authors:  Lawrence L Creswell; John C Alexander; T Bruce Ferguson; Alan Lisbon; Lee A Fleisher
Journal:  Chest       Date:  2005-08       Impact factor: 9.410

9.  Cost-effectiveness of targeting patients undergoing cardiac surgery for therapy with intravenous amiodarone to prevent atrial fibrillation.

Authors:  Elizabeth M Mahoney; Trevor D Thompson; Emir Veledar; Jovonne Williams; William S Weintraub
Journal:  J Am Coll Cardiol       Date:  2002-08-21       Impact factor: 24.094

10.  Postoperative atrial fibrillation and mortality after coronary artery bypass surgery.

Authors:  Rollo P Villareal; Ramesh Hariharan; Brant C Liu; Biswajit Kar; Vei-Vei Lee; MacArthur Elayda; J Alberto Lopez; Abdi Rasekh; James M Wilson; Ali Massumi
Journal:  J Am Coll Cardiol       Date:  2004-03-03       Impact factor: 24.094

View more
  6 in total

1.  New-Onset Atrial Fibrillation After Coronary Artery Bypass Graft and Long-Term Risk of Stroke: A Meta-Analysis.

Authors:  Matthew R Megens; Leonid Churilov; Vincent Thijs
Journal:  J Am Heart Assoc       Date:  2017-12-22       Impact factor: 5.501

2.  Six-month prognostic impact of hemodynamic profiling by short minimally invasive monitoring after cardiac surgery.

Authors:  Cristina Giglioli; Emanuele Cecchi; Pier Luigi Stefàno; Valentina Spini; Giacomo Fortini; Marco Chiostri; Niccolò Marchionni; Salvatore Mario Romano
Journal:  J Cardiovasc Thorac Res       Date:  2020-12-13

3.  Is the Preoperative Administration of Amiodarone or Metoprolol More Effective in Reducing Atrial Fibrillation: After Coronary Bypass Surgery?

Authors:  Oruc Alper Onk; Bilgehan Erkut
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

4.  The use of monocyte to HDL ratio to predict postoperative atrial fibrillation after aortocoronary bypass graft surgery.

Authors:  Ahmet Ilker Tekkesin; Mert Ilker Hayiroglu; Regayip Zehir; Ceyhan Turkkan; Muhammed Keskin; Goksel Cinier; Ahmet Taha Alper
Journal:  North Clin Istanb       Date:  2017-08-26

5.  Relationship between perioperative left atrial appendage doppler velocity estimates and new-onset atrial fibrillation in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass.

Authors:  Kunal Sarin; Sandeep Chauhan; Akshay K Bisoi; Poonam Malhotra Kapoor; Parag Gharde; Arindam Choudhury
Journal:  Ann Card Anaesth       Date:  2017 Oct-Dec

6.  Botulinum Toxin-Chitosan Nanoparticles Prevent Arrhythmia in Experimental Rat Models.

Authors:  David Sergeevichev; Vladislav Fomenko; Artem Strelnikov; Anna Dokuchaeva; Maria Vasilieva; Elena Chepeleva; Yanina Rusakova; Sergey Artemenko; Alexander Romanov; Nariman Salakhutdinov; Alexander Chernyavskiy
Journal:  Mar Drugs       Date:  2020-08-02       Impact factor: 5.118

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.